Transcatheter mitral valve repair: An overview of current and future devices

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Transcatheter mitral valve repair : An overview of current and future devices. / De Backer, Ole; Wong, Ivan; Taramasso, Maurizio; Maisano, Francesco; Franzen, Olaf; Søndergaard, Lars.

I: Open Heart, Bind 8, Nr. 1, e001564, 28.04.2021, s. 1-13.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

De Backer, O, Wong, I, Taramasso, M, Maisano, F, Franzen, O & Søndergaard, L 2021, 'Transcatheter mitral valve repair: An overview of current and future devices', Open Heart, bind 8, nr. 1, e001564, s. 1-13. https://doi.org/10.1136/openhrt-2020-001564

APA

De Backer, O., Wong, I., Taramasso, M., Maisano, F., Franzen, O., & Søndergaard, L. (2021). Transcatheter mitral valve repair: An overview of current and future devices. Open Heart, 8(1), 1-13. [e001564]. https://doi.org/10.1136/openhrt-2020-001564

Vancouver

De Backer O, Wong I, Taramasso M, Maisano F, Franzen O, Søndergaard L. Transcatheter mitral valve repair: An overview of current and future devices. Open Heart. 2021 apr. 28;8(1):1-13. e001564. https://doi.org/10.1136/openhrt-2020-001564

Author

De Backer, Ole ; Wong, Ivan ; Taramasso, Maurizio ; Maisano, Francesco ; Franzen, Olaf ; Søndergaard, Lars. / Transcatheter mitral valve repair : An overview of current and future devices. I: Open Heart. 2021 ; Bind 8, Nr. 1. s. 1-13.

Bibtex

@article{7ba21792748947cc8f1b07a5034cf5a7,
title = "Transcatheter mitral valve repair: An overview of current and future devices",
abstract = "The field of transcatheter mitral valve repair (TMVr) for mitral regurgitation (MR) is rapidly evolving. Besides the well-established transcatheter mitral edge-to-edge repair approach, there is also growing evidence for therapeutic strategies targeting the mitral annulus and mitral valve chordae. A patient-tailored approach, careful patient selection and an experienced interventional team is crucial in order to optimise procedural and clinical outcomes. With further data from ongoing clinical trials to be expected, consensus in the Heart Team is needed to address these complexities and determine the most appropriate TMVr therapy, either single or combined, for patients with severe MR. ",
keywords = "endovascular procedures, heart valve prosthesis implantation, mitral valve insufficiency",
author = "{De Backer}, Ole and Ivan Wong and Maurizio Taramasso and Francesco Maisano and Olaf Franzen and Lars S{\o}ndergaard",
note = "Publisher Copyright: {\textcopyright} ",
year = "2021",
month = apr,
day = "28",
doi = "10.1136/openhrt-2020-001564",
language = "English",
volume = "8",
pages = "1--13",
journal = "Open Heart",
issn = "2398-595X",
publisher = "BMJ",
number = "1",

}

RIS

TY - JOUR

T1 - Transcatheter mitral valve repair

T2 - An overview of current and future devices

AU - De Backer, Ole

AU - Wong, Ivan

AU - Taramasso, Maurizio

AU - Maisano, Francesco

AU - Franzen, Olaf

AU - Søndergaard, Lars

N1 - Publisher Copyright: ©

PY - 2021/4/28

Y1 - 2021/4/28

N2 - The field of transcatheter mitral valve repair (TMVr) for mitral regurgitation (MR) is rapidly evolving. Besides the well-established transcatheter mitral edge-to-edge repair approach, there is also growing evidence for therapeutic strategies targeting the mitral annulus and mitral valve chordae. A patient-tailored approach, careful patient selection and an experienced interventional team is crucial in order to optimise procedural and clinical outcomes. With further data from ongoing clinical trials to be expected, consensus in the Heart Team is needed to address these complexities and determine the most appropriate TMVr therapy, either single or combined, for patients with severe MR.

AB - The field of transcatheter mitral valve repair (TMVr) for mitral regurgitation (MR) is rapidly evolving. Besides the well-established transcatheter mitral edge-to-edge repair approach, there is also growing evidence for therapeutic strategies targeting the mitral annulus and mitral valve chordae. A patient-tailored approach, careful patient selection and an experienced interventional team is crucial in order to optimise procedural and clinical outcomes. With further data from ongoing clinical trials to be expected, consensus in the Heart Team is needed to address these complexities and determine the most appropriate TMVr therapy, either single or combined, for patients with severe MR.

KW - endovascular procedures

KW - heart valve prosthesis implantation

KW - mitral valve insufficiency

UR - http://www.scopus.com/inward/record.url?scp=85105168563&partnerID=8YFLogxK

U2 - 10.1136/openhrt-2020-001564

DO - 10.1136/openhrt-2020-001564

M3 - Review

C2 - 33911022

AN - SCOPUS:85105168563

VL - 8

SP - 1

EP - 13

JO - Open Heart

JF - Open Heart

SN - 2398-595X

IS - 1

M1 - e001564

ER -

ID: 302819536